Filter
112
Filtered Results: 112
Text search:
M.
Vitoriaa
Featured
Recommendations
15
New Publications
23
Language
Document type
No document type
72
Guidelines
22
Studies & Reports
15
Fact sheets
2
Manuals
1
Countries / Regions
Eastern Europe
5
Russia
4
Ukraine
2
Armenia
2
Global
2
Latin America and the Carribbean
2
Western and Central Europe
2
Brazil
2
North Macedonia
1
Thailand
1
Estonia
1
Mozambique
1
Africa
1
Eastern Europe and Central Asia
1
North America
1
Belgium
1
Belarus
1
South Africa
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
HIV & STI
16
TB
3
Communicable Diseases
2
Hepatitis
2
NCD
2
Cardiovascular Diseases
2
Guidelines
2
Maternal Health
2
Paediatrics
1
Buruli Ulcer
1
Humanitarian Aid
1
COVID-19
1
Public Health
1
Sexual Violence
1
Pediatrics
1
Countries
1
Child protection
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
Humanitarian Crisis
1
Other
1
WASH
1
Gynaecology & Obstetrics
1
Neurology & Psychology
1
Water
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
12
HIV in Key Populations
12
TB/HIV Coinfection
11
Clinical Aspects, Treatment & Prevention
10
Transgender People
8
Treatment Guidelines HIV
6
ART Drug Resistance
5
General
5
Treatment & Prevention
4
Children & Adolescents
4
Drug resistance
4
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
4
HIV testing & services
3
Clinical Aspects
3
Opportunistic Infections
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Reports & Studies
3
Policies & Strategies
2
General Reports
2
TB & Drug Abuse
2
Prevention & Control
2
Eastern Europe
2
Men who have sex with men (MSM)
2
TB/HIV
2
Drug resistant TB
2
Neurological Disorders
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
TB/HIV Global
2
Latin America & the Carribean
2
Clinical Guidelines
2
HIV service delivery
2
Drugs
1
Public Health
1
Childhood TB
1
Background PTSD in children
1
Vaccines & Immunization
1
Yellow Fever
1
Violence & Protection
1
Adults
1
HIV surveillance
1
Prevention Guidelines
1
Schizophrenia
1
HIV testing & disclosure
1
Hepatitis
1
HIV
1
General Studies & Reports
1
Others
1
Prophylaxis
1
Vaccination
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Reports
1
Russia
1
Sex Worker
1
Manuals
1
Key Resources
1
Laboratory
1
Studies
1
Infection Prevention & Hygiene
1
COVID-19
1
Country Specific
1
For Migrants & Refugees
1
Country specific documents
1
Prison & Detention
1
Child Protection
1
Paediatrics
1
Children & Mental Health
1
Oxygen Therapy
1
Gambling
1
Community Health Workers CHW
1
HIV &TB
1
Epilepsy
1
Mental Disorders
1
Prevention & Measures
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Awareness
1
Clinical Aspects & Diagnosis
1
Armenia
1
General
1
Detection & Diagnosis
1
Policies and guidelines
1
Community Worker
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Nutrition
1
Research & Access
1
HIV and coinfection
1
WASH
1
Epidemiology
1
Depression
1
Eastern and Southern Africa
1
Cyclones Idai & Kenneth
1
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
July 2019
Policy brief
HIV Treatment
Guidelines
June 2017
HIV strategic information for impact
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders – especially severe mental disorders (SMD) – are linked with poorer health outcomes and increase...
BMC Public Health, Volume 18, Article number: 303 (2018)
https://doi.org/10.1186/s12889-018-5208-0
Published: 02 March 2018
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Las infecciones de transmisión sexual (ITS) constituyen un importante problema de salud pública en todo el mundo, que afecta a la calidad de vida y se acompaña de importantes niveles de morbilidad y mortalidad. Estas infecciones influyen directamente en la salud infantil y reproductiva porque tra...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
